Reuters. The U.S. Food and Drug Administration said on Tuesday it authorized Abbott Laboratories’ glucose monitor, making it the first device that continuously monitors both ketone levels and blood sugar.
Here are some details:
- The device branded as Libre Duo 10 Day is designed for a 10-day wear period for people aged 2 years and older living with diabetes.
- The biowearable is designed to alert people of rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency, a serious health complication for people with diabetes.
- Unlike earlier ketone tests that offered only separate, one-time readings, Abbott’s device continuously monitors both ketone and glucose levels, displaying real-time trends.
Read more- at the source
This illustration was created using artificial intelligence technology and is not a documentary image.
